Navigation Links
Imagenetix, Inc. Reports First Quarter 2010 Results
Date:8/10/2009

SAN DIEGO, Aug. 10 /PRNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX) announced today results for its first fiscal quarter ended June 30, 2009. Net sales increased 22% for the quarter to $1,702,000 from the $1,394,000 reported for the same period last year.

Net loss for the quarter was ($415,000) or ($.04) per share compared to a net profit for the same period of the prior fiscal year of $587,000 or $0.05 per share. The prior fiscal year period was positively impacted by a one time settlement of $1,785,000.

Commenting on the results of the first quarter, Mr. William Spencer, Imagenetix Chief Executive Officer said, "We were encouraged by the increase in sales of our weight loss product and of our own branded product, InflameAway Celadrin, which is beginning to be well received in the food, drug and mass market segments. However, we were disappointed that sales of our raw material to wholesalers and distributors came in lower compared to the previous year as they became negatively impacted by current economic conditions. We continue to expand advertising and marketing to assure increased awareness and acceptability of InflameAway Celadrin. We anticipate this marketing program for the mass market segment to continue to result in improved sales during the balance of our current fiscal year."

About Imagenetix

Imagenetix, based in San Diego, California, is an innovator of scientifically tested, natural-based, proprietary, bioceutical products developed to enhance human health on a global basis. Imagenetix develops and formulates propriety over-the-counter topical creams, skincare products and nutritional supplements to be marketed globally through multiple channels of distribution. In addition, the company develops patentable compounds for entering into licensing agreements with pharmaceutical partner
'/>"/>

SOURCE Imagenetix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Imagenetix, Inc. Reports Second Quarter and Six Month Results
2. Vanda Pharmaceuticals Reports Second Quarter 2009 Results
3. SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
4. Novavax Reports Second Quarter 2009 Financial Results
5. Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
6. NeurogesX Reports Second Quarter 2009 Results
7. American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
8. AutoImmune Inc. Reports 2009 Second Quarter Financial Results
9. Synthetech Reports First Quarter Fiscal 2010 Results
10. GenVec Reports Second Quarter 2009 Financial Results
11. InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... LOS ANGELES , May 20, 2013 ... San Francisco , James ... of Clinical Psychiatry at the Semel Institute for Neuroscience ... of Medicine at the University of California ... in both Child and Adolescent Psychopharmacology and ADHD at ...
(Date:5/20/2013)... , May 20, 2013 Pacific Biomarkers and Clinigene ... for developers of biosimilars at the 2013 AAPS/ ... San Diego Hotel and Marina , ... have the opportunity to speak with company representatives at ... That Cross" on May 21 from 1-2 p.m. in ...
(Date:5/20/2013)... HILL, N.C. , May 20, 2013 /PRNewswire/ ... company focused on developing differentiated antibiotics to meet ... infections, today announced that it presented data at ... in Philadelphia demonstrating the ... levofloxacin in Cempra,s prior Phase 2 clinical trial ...
(Date:5/20/2013)... May 20, 2013 Interventional cardiologist Tony ... General Hospital (AGH) Cardiovascular Institute have helped pioneer ... artery disease (CAD) over the past three decades, ... balloon angioplasty and coronary artery stent implantation. , Today, ... play a prominent role in the study of a ...
Breaking Biology Technology:Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4
... global provider of enterprise information quality solutions, and ... solutions company based in Connecticut, have verbally agreed not ... 15, concluding Pitney's planned acquisition of Firstlogic. , ,The ... a review of a Second Request for Information issued ...
... Health and Human Services Tommy Thompson has been elected to ... of information systems for high-acuity care areas of a hospital, ... intensive care unit. , ,Thompson began his career in public ... He was elected assistant Assembly minority leader in 1973 and ...
... Wisconsin company specializing in functional Magnetic Resonance Imaging ... the 2005 edition of the Minnies, awarded by ... and related professionals in medical imaging. , ,This ... categories. AuntMinnie.com members voted Neurognostics one of the ...
Cached Biology Technology:
(Date:5/20/2013)... effect of physical education (PE) on child weight, but ... the amount of time that elementary schoolchildren spent in ... study represents some of the first evidence of a ... forthcoming in the Journal of Health Economics . ... be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The research ...
(Date:5/20/2013)... grant will help establish the Center for Advanced Research ... of Illinois at Urbana-Champaign and Worcester Polytechnic Institute (WPI) ... research in drying moist, porous materials such as food ... products; textiles; and biopharmaceuticals," said Hao Feng, a U ... and the Illinois site director. , According to Feng, ...
(Date:5/20/2013)... Geology articles posted online ahead of print ... swath of geoscience subdisciplines, including minerals exploration, archaeology, ... studied include Siberia; the Sumatran subduction margin; the ... Mars; and the Southeastern U.S. Atlantic Margin. Brief ... plate tectonics;, 2. The clear fingerprint of ice ...
Breaking Biology News(10 mins):Gym class reduces probability of obesity, study finds for first time 2NSF approves planning grant for Center for Advanced Research in Drying 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11
... Ala. The newest generation of compact research freezers ... the scientific capacity of the International Space Station (ISS), ... (UAB). A UAB-designed cryogenic freezer called GLACIER, short ... its NASA debut in late 2008 aboard a shuttle ...
... the latest American Chemical Society (ACS) Weekly ... It has news from ACS, 34 peer-reviewed ... .,Please credit the individual journal or the ... this information. PressPac Archive: http://portal.acs.org/portal/acs/corg/content?_nfpb=true&_pageLabel=PP_ARTICLEMAIN&node_id=223&content_id=CTP_006742&use_sec=true&sec_url_var=region1 ...
... a new approach to prevent bacterial infections from taking ... , Dr Quinn Parks and colleagues describe how they ... cells to prevent Pseudomonas aeruginosa bacteria from ... both the body,s immune mechanisms and antibiotics. When ...
Cached Biology News:American Chemical Society's weekly PressPac -- March 11, 2009 2American Chemical Society's weekly PressPac -- March 11, 2009 3American Chemical Society's weekly PressPac -- March 11, 2009 4American Chemical Society's weekly PressPac -- March 11, 2009 5American Chemical Society's weekly PressPac -- March 11, 2009 6
Mouse monoclonal antibody raised against a partial recombinant CENTB2. NCBI Entrez Gene ID = CENTB2...
Mouse monoclonal antibody raised against a partial recombinant STAU2. NCBI Entrez Gene ID = STAU2...
...
Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
Biology Products: